Organersatz auf der Intensivstation – Extrakorporaler Leberersatz

Abstract

Extracorporeal liver support systems aim to prevent deterioration of liver failure by reducing endogenous liver toxins accumulating in liver dysfunction. Currently, four artificial liver support devices are available in clinical routine: the Molecular Adsorbent Recirculating System (MARS), Single Pass Albumin Dialysis (SPAD), OPen ALbumin Dialysis (OPAL) and the Prometheus System. All systems were shown to alter water soluble and protein bound substances accumulating in liver failure, but most clinical experience was gained with MARS. Despite improvement in clinical condition none of the aforementioned devices were shown to improve patient survival. Thus, more clinical studies addressing timing, dosing and clear (contra-)indications are needed.

• Literatur

• 1 Recknagel P, Gonnert FA, Westermann M et al. Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitis. PLoS Med 2012; 9: e1001338
• 2 Gonnert F, Bauer M, Kortgen A. Current aspects of diagnostics of hepatic dysfunction in critically ill. Dtsch Med Wochenschr 1946 2012; 137: 2212-2216
• 3 Mitzner SR. Extracorporeal liver support-albumin dialysis with the Molecular Adsorbent Recirculating System (MARS). Ann Hepatol 2011; 10: 21-28
• 4 Ghuman J, Zunszain PA, Petitpas I et al. Structural basis of the drug-binding specificity of human serum albumin. J Mol Biol 2005; 353: 38-52
• 5 Tritto G, Davies NA, Jalan R. Liver replacement therapy. Semin Respir Crit Care Med 2012; 33: 70-79
• 6 Saliba F, Samuel D. Artificial liver support: a real step forward. Minerva Med 2015; 105: 35-43
• 7 Kortgen A, Rauchfuss F, Götz M et al. Albumin dialysis in liver failure: comparison of molecular adsorbent recirculating system and single pass albumin dialysis – a retrospective analysis. Ther Apher Dial Off Peer-Rev J Int Soc Apher Jpn Soc Apher Jpn Soc Dial Ther 2009; 13: 419-425
• 8 Benyoub K, Muller M, Bonnet A et al. Amounts of bile acids and bilirubin removed during single-pass albumin dialysis in patients with liver failure. Ther Apher Dial Off Peer-Rev J Int Soc Apher Jpn Soc Apher Jpn Soc Dial Ther 2011; 15: 504-506
• 9 Stadlbauer V, Krisper P, Beuers U et al. Removal of bile acids by two different extracorporeal liver support systems in acute-on-chronic liver failure. ASAIO J Am Soc Artif Intern Organs 1992 2007; 53: 187-193
• 10 Woolbright BL, McGill MR, Staggs VS et al. Glycodeoxycholic Acid Levels as Prognostic Biomarker in Acetaminophen-Induced Acute Liver Failure Patients. Toxicol Sci Off J Soc Toxicol 2014; 142: 436-444